Evidence map›Paper›PMID 15695582›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2005

Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human.

Huai-Dong Song, Chang-Chun Tu, Guo-Wei Zhang, Sheng-Yue Wang, Kui Zheng, Lian-Cheng Lei, Qiu-Xia Chen, Yu-Wei Gao, Hui-Qiong Zhou, Hua Xiang and 49 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04420260 (Scheme of Primary Prevention of Infection by COVID-19, in Workers), which is not on this map. Cited by 422 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
422citing papers in PubMed, 4 pooled it
19.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04420260 nacompletednot on this mapstarted 2021, after this paper: background citation

Scheme of Primary Prevention of Infection by COVID-19, in Workers: Phase II Controlled Clinical Trial, to be Carried Out in Medellín-Antioquia

TypeinterventionalSponsorUnidad de Investigación Genética MolecularRan2021 to 2021Enrolled152ConditionsCOVIDArmsGroup A: oropharygeal spray and immunostimulant emulsion, Group D:Placebo oropharyngeal spray + Placebo taken PO
3 · Its place in the literature

Who cites it

422 citing papers in PubMed, 4 syntheses or guidelines pooled it, 734 citations in OpenAlex.

  1. Globally approved vaccines for COVID-19: a systematic review.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

362 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

59 authors at 1 institution in 1 country.

Huai-Dong SongState Key Laboratory for Medical Genomics/Pôle Sino-Français de Recherche en Sciences du Vivant et Génomique, Ruijin Hospital Affiliated to Shanghai Second Medical University, 197 Rui Jin Road II, Shanghai 200025, China.
Chang-Chun Tu
Guo-Wei Zhang
Sheng-Yue Wang
Kui Zheng
Lian-Cheng Lei
Qiu-Xia Chen
Yu-Wei Gao
Hui-Qiong Zhou
Hua Xiang
Hua-Jun Zheng
Shur-Wern Wang Chern
Feng Cheng
Chun-Ming Pan
Hua Xuan
Sai-Juan Chen
Hui-Ming Luo
Duan-Hua Zhou
Yu-Fei Liu
Jian-Feng He
Peng-Zhe Qin
Ling-Hui Li
Yu-Qi Ren
Wen-Jia Liang
Ye-Dong Yu
Larry Anderson
Ming Wang
Rui-Heng Xu
Xin-Wei Wu
Huan-Ying Zheng
Jin-Ding Chen
Guodong Liang
Yang Gao
Ming Liao
Ling Fang
Li-Yun Jiang
Hui Li
Fang Chen
Biao Di
Li-Juan He
Jin-Yan Lin
Suxiang Tong
Xiangang Kong
Lin Du
Pei Hao
Hua Tang
Andrea Bernini
Xiao-Jing Yu
Ottavia Spiga
Zong-Ming Guo
Hai-Yan Pan
Wei-Zhong He
Jean-Claude Manuguerra
Arnaud Fontanet
Antoine Danchin
Neri Niccolai
Yi-Xue Li
Chung-I Wu
Guo-Ping Zhao
Chinese National Human Genome Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The genomic sequences of severe acute respiratory syndrome coronaviruses from human and palm civet of the 2003/2004 outbreak in the city of Guangzhou, China, were nearly identical. Phylogenetic analysis suggested an independent viral invasion from animal to human in this new episode. Combining all existing data but excluding singletons, we identified 202 single-nucleotide variations. Among them, 17 are polymorphic in palm civets only. The ratio of nonsynonymous/synonymous nucleotide substitution in palm civets collected 1 yr apart from different geographic locations is very high, suggesting a rapid evolving process of viral proteins in civet as well, much like their adaptation in the human host in the early 2002-2003 epidemic. Major genetic variations in some critical genes, particularly the Spike gene, seemed essential for the transition from animal-to-human transmission to human-to-human transmission, which eventually caused the first severe acute respiratory syndrome outbreak of 2002/2003.

Indexed as

Evolution, MolecularAmino Acid SubstitutionAnimalsChinaDisease OutbreaksGenes, ViralHumansMembrane GlycoproteinsPhylogenyPolymorphism, Single NucleotideSevere Acute Respiratory SyndromeSevere acute respiratory syndrome-related coronavirusSpecies SpecificitySpike Glycoprotein, CoronavirusViral Envelope ProteinsViverridaeMembrane GlycoproteinsSpike Glycoprotein, CoronavirusViral Envelope Proteins

Identifiers

PMID15695582
PMCPMC548959
OpenAlexW1990059132

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.